APO
Apollo Global Management, Inc.
APO offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
GS
The Goldman Sachs Group, Inc.
GS has the edge over APO overall, supported by stronger fundamentals and lower modeled downside.
APO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| N/A | |
| N/A |
APO's revenue is currently stable, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like APO.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
APO PE Valuation
APO has no meaningful PE right now: it lost money over the past year.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
APO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for APO, with profitability holding steady.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
GS has the edge over APO on the outlook, with more favorable profitability expectations.
APO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.14 | — |
| Q3 2026 | -$1.81 | -126% |
| Q2 2026 | $2.75 | -49% |
| Q1 2026 | $1.59 | -72% |
| Q4 2025 | $5.54 | -24% |
| Q3 2025 | $6.86 | -27% |
| Q2 2025 | $5.37 | -42% |
| Q1 2025 | $5.73 | -36% |
| Q4 2024 | $7.33 | -11% |
APO has swung to a loss: it lost $1.81 per share over the past year, after a profit the year before.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over APO on earnings quality, reporting a profit while its opponent remains loss making.
APO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.7B | -52% |
| Q2 2026 | $11.2B | +64% |
| Q1 2026 | $5.1B | -8.8% |
| Q4 2025 | $9.9B | +87% |
| Q3 2025 | $9.8B | +26% |
| Q2 2025 | $6.8B | +13% |
| Q1 2025 | $5.5B | -21% |
| Q4 2024 | $5.3B | -52% |
APO's revenue is growing: $4.7B last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -31% | -60 points |
| Q2 2026 | 22% | +9.9 points |
| Q1 2026 | 5.6% | -16 points |
| Q4 2025 | 18% | -15 points |
| Q3 2025 | 30% | +2.7 points |
| Q2 2025 | 12% | -12 points |
| Q1 2025 | 21% | -9.8 points |
| Q4 2024 | 33% | +15 points |
APO's operating margin was −31% last quarter, down 60 points from the same quarter a year ago.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over APO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over APO on profitability, with a higher operating margin.
APO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $136M | -55% |
| Q2 2026 | $2.9B | +128% |
| Q1 2026 | $1.6B | +60% |
| Q4 2025 | $4.7B | +$4.7B |
| Q3 2025 | $303M | -84% |
| Q2 2025 | $1.3B | -5.3% |
| Q1 2025 | $1B | +1346% |
| Q4 2024 | -$4M | -100% |
APO has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
APO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -7.6M shares |
| 1 year | -0.9% | -5.2M shares |
| 3 years | +4.1% | +23.8M shares |
| 5 years | +152% | +363M shares |
| Available history | +170% | +380M shares |
APO has 603M diluted shares, down 0.9% from a year ago, with $1.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $118M |
| Q2 2026 | $97M |
| Q1 2026 | $632M |
| Q4 2025 | $240M |
| Q3 2025 | $340M |
| Q2 2025 | — |
| Q1 2025 | $193M |
| Q4 2024 | $102M |
APO spent $1.1B buying back its own shares over the past year, up 71% from the year before.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over APO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
APO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
APO has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like APO.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over APO on leverage, with a lower net debt burden relative to earnings.
APO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 23.4 | Neutral |
APO's weekly RSI is 49 (neutral) and its Stochastic is 23 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
APO PE vs Financial Services Sector
| Metric | APO | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 13x | 224% above |
| PE % | 85 | 63 | 22 pts above |
APO has no meaningful PE right now: it lost money over the past year.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS has the edge over APO on valuation relative to its sector.
APO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $116.5 | 4.2% above |
| 20 week MA | $123.2 | 1.5% below |
| 50 week MA | $126.1 | 3.7% below |
| 100 week MA | $133.4 | 9% below |
| 200 week MA | $116.4 | 4.2% above |
APO's trend is mixed: it's above two of its five weekly moving averages, and 4.2% above its 200-week average.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS has the edge over APO on trend strength, trading above more of its moving averages.
APO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.1 | $49.1 | +2.1% |
| 2021 | $49.1 | $74.3 | +51% |
| 2022 | $74.3 | $64.3 | -13% |
| 2023 | $64.3 | $93.2 | +45% |
| 2024 | $93.2 | $170.3 | +83% |
| 2025 | $170.3 | $148.5 | -13% |
| 2026 YTD | $148.5 | $121.4 | -18% |
APO has finished higher in four of the last six years, two of them by more than 50%. It's down 18% so far in 2026.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has the edge over APO on returns for 2026, with the stronger performance.